GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mymetics MYMX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2023

Revenue

€6,000

FY2014FY2023

Net income

−€11.6m

FY2014FY2023

Free cash flow

−€1.7m

FY2014FY2023

Shareholders' equity

—

FY2014FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue€6,000€3,000€3,000€35,000€111,000€75,000€202,000€1.3m€3.2m€2.4m
Research and development—€1,442€975,000€1.1m€970,000€1.2m€2.1m€1.0m€1.7m€1.6m
Operating income−€2.4m−€1.7m−€1.6m−€1.6m−€1.4m−€1.5m−€1.5m−€3.4m−€393,000−€667,000
Net income−€11.6m−€4.8m−€4.7m−€4.2m−€4.2m−€4.2m−€4.1m−€6.0m−€3.0m−€3.3m
Diluted earnings per share-0.04-0.02-0.02-0.01-0.01-0.01-0.01-0.02-0.01-0.01

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets—€7.3m€7.6m€8.1m€7.7m€7.8m€8.0m€8.3m€11.7m€11.0m
Cash and short-term investments—€313,000€571,000€1.1m€683,000€479,000€1.2m€1.4m€2.4m€1.6m
Total liabilities—€72.2m€67.7m€63.4m€58.9m€54.8m€50.9m€47.1m€44.6m€41.1m
Debt—€72.0m€67.7m€63.4m€58.7m€54.8m€50.4m€45.8m€43.2m€40.4m
Shareholders' equity—−€64.9m−€60.1m−€55.4m−€51.2m−€47.0m−€42.9m−€38.8m−€32.9m−€30.1m
Shares outstanding304m304m304m304m304m304m304m304m304m302m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−€1.7m−€1.7m−€1.7m−€1.7m−€972,000−€2.3m−€2.5m−€987,000€730,000€3.0m
Capital spending—−€2,000−€10,000−€14,000−€36,000−€36,000−€37,000−€3,000−€20,000−€45,000
Free cash flow−€1.7m−€1.7m−€1.7m−€1.7m−€1.0m−€2.3m−€2.5m−€990,000€710,000€2.9m

Latest quarters

By quarter end

Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021
Revenue€36,986€201,343€3,000€3,000€130,000€297,000€485,000€55,000
Operating income−€381,000−€291,000−€1.2m−€487,000−€399,000−€430,000−€429,000−€445,000
Net income−€1.1m−€7.7m−€1.9m−€907,000−€2.3m−€2.3m−€2.0m−€1.2m
Diluted earnings per share-0.00-0.03-0.01-0.00-0.01-0.01-0.01-0.00
Total assets€100,000€533,000€7.3m€7.3m€7.5m€7.3m€7.5m€7.6m
Cash and short-term investments€62,000€402,000€335,000—€401,000€350,000€122,000€571,000
Debt€75.1m€74.3m€73.1m€156,000€71.3m€69.8m€68.3m€67.5m
Shareholders' equity−€75.6m−€74.5m−€66.8m−€64.9m−€64.0m−€62.6m−€61.3m−€60.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-44.4%-39.7%-48.3%
Operating income15.7%9.9%—
Net income40.6%22.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-46488.9%-15761.7%-4424.0%-65.8%
Net margin-181911.1%-53744.7%-14428.8%-378.3%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2000-to-1 reverse split · 29 Dec 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.